Table 1.
Control Subjects | ||||
---|---|---|---|---|
Plasma | Serum | |||
Men | Women | Men | Women | |
N | 30 | 29 | 32 | 25 |
Men/women | 30/0 | 0/30 | 32/0 | 0/25 |
Age, y | 59 ± 17 | 56 ± 16 | 56 ± 18 | 59 ± 14 |
TC, mg/dL | 157 ± 28 | 175 ± 24 | 185 ± 39 | 189 ± 38 |
HDL-C, mg/dl | 53 ± 11 | 67 ± 13* | 53 ± 13 | 68 ± 15* |
LDL-C, mg/dL | 93 ± 21 | 95 ± 17 | 117 ± 36 | 103 ± 27 |
TG, mg/dL | 87 ± 37 | 78 ± 23 | 102 ± 30 | 95 ± 39 |
sdLDL-C, mg/dL | 17 ± 7 | 19 ± 8 | 27 ± 8 | 25 ± 12 |
Apo A-I, mg/dL | 148 ± 19 | 170 ± 25 | 154 ± 28 | 182 ± 28 |
Antioxidative capacity of HDL (HII) | 0.28 ± 0.04 | 0.30 ± 0.05 | 0.38 ± 0.06** | 0.38 ± 0.05** |
*p < 0.05, compared to men
**p < 0.05 compared to plasma